Grifols, a private plasma donation clinic, recently announced a significant revision in its reporting of serious injuries and fatalities associated with its clinics in Canada. Initially reporting 25 incidents since 2018, the company has now stated that the correct number is just six. This revision comes in the wake of two donor deaths, which prompted Grifols to temporarily halt plasma collection at its clinics across the country.
Following the announcement of the deaths, Grifols's facilities have paused all plasma collections as a precautionary measure. Health Canada has been investigating the reported adverse reactions and noted that many of the serious medical conditions purportedly linked to plasma donations were misclassified by Grifols. This has raised questions about the accuracy of the company’s reporting practices regarding donor safety.
The situation has heightened scrutiny on plasma donation practices in Canada and the protocols that clinics must follow to ensure donor safety. Stakeholders in the healthcare and regulatory sectors are expected to closely monitor the developments as more information becomes available.
Analyzed Canadian Outlets (2)
2 headlines